SCHEMBL3394246

SCHEMBL3394246

CCCCCCCCCCCCOS(=O)(=O)c1ccccc1CCCCCCCCCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.45
CA1 P00915 8/20 0.42
CA2 P00918 8/20 0.42
CA9 Q16790 7/20 0.42
CA12 O43570 3/20 0.42
CA7 P43166 3/20 0.42
CA14 Q9ULX7 3/20 0.42
CA3 P07451 2/20 0.42
CA4 P22748 2/20 0.42
CA6 P23280 2/20 0.42
CA5A P35218 2/20 0.42
CA5B Q9Y2D0 2/20 0.42
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
RECQL P46063 2/20 0.41
TSHR P16473 2/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL439295 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL27680666 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL27284649 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL27612464 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL27286822 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL10008852 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL3394227 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL15910842 1.00 LIPG (0.45) LIPGCA1CA2CA9CA12
SCHEMBL28406123 0.98 LIPG (0.44) LIPGCA1CA2CA9CA12
Phosphine SCHEMBL2030531 0.98 LIPG (0.44) LIPGCA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130216723-A1 SULFONATE ESTERS AS LATENT ACID CATALYSTS KING INDUSTRIES (US) 2013-08-22 US claimed
EP-2203519-A1 SULFONATE ESTERS AS LATENT ACID CATALYSTS King Industries (US) 2010-07-07 EP claimed
US-20090104363-A1 Sulfonate esters as latent acid catalysts KING INDUSTRIES 2009-04-23 US claimed
WO-2009045466-A1 SULFONATE ESTERS AS LATENT ACID CATALYSTS KING INDUSTRIES (US) 2009-04-09 WO claimed
EP-2762516-B1 POLYCARBONATE AND METHOD FOR PREPARING SAME CHEIL IND INC (KR) 2016-10-12 EP disclosed
CN-102558810-B Polycarbonate resin composition and molded product formed of the same CHEIL IND INC 2014-09-24 CN disclosed
EP-2762516-A1 POLYCARBONATE AND METHOD FOR PREPARING SAME Cheil Industries Inc. (KR) 2014-08-06 EP disclosed
CN-103946267-A Polycarbonate, production method for same and optical film comprising same CHEIL IND INC 2014-07-23 CN disclosed
CN-103897164-A Polycarbonate resin for film, method for preparing the same and film including the same CHEIL IND INC 2014-07-02 CN disclosed
US-8598257-B2 Polycarbonate resin composition CHEIL INDUSTRIES INC. (KR) 2013-12-03 US disclosed
CN-102558810-A Polycarbonate resin composition and molded product formed of the same CHEIL IND INC 2012-07-11 CN disclosed
US-20120172497-A1 Polycarbonate Resin Composition CHEIL INDUSTRIES INC. (KR) 2012-07-05 US disclosed
CN-1066675-A The low-sulfur diesel fuels that contains organometallic complex LUBRIZOL CORP (US) 1992-12-02 CN disclosed
CN-1066676-A Diesel fuel containing organometallic complexes LUBRIZOL CORP (US) 1992-12-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104363-A1 Sulfonate esters as latent acid catalysts ORAI1, SARAF, NAPA LIPG 991/4885CA1 173/4885CA2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.